Loading…
Pheochromocytoma and paraganglioma : Importance of diagnostic imaging
If pheochromocytoma (PC) or paraganglioma (PGL) is diagnosed based on serologic studies, imaging is required to locate the adrenal mass for further management. Besides pathognomonic hormonal findings, PC/PGL can exhibit typical imaging features. However, PC/PGL can also show morphological overlap wi...
Saved in:
Published in: | Radiologe 2019-11, Vol.59 (11), p.975-981 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | ger |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 981 |
container_issue | 11 |
container_start_page | 975 |
container_title | Radiologe |
container_volume | 59 |
creator | Kunz, W G Auernhammer, C J Nölting, S Pfluger, T Ricke, J Cyran, C C |
description | If pheochromocytoma (PC) or paraganglioma (PGL) is diagnosed based on serologic studies, imaging is required to locate the adrenal mass for further management. Besides pathognomonic hormonal findings, PC/PGL can exhibit typical imaging features. However, PC/PGL can also show morphological overlap with other pathologies.
The modality of choice for evaluation of PC is CT. In case of extra-adrenal location, MRI is superior to CT. Imaging with PET-CT provides complementary information in the differentiation of PC/PGL and is recommended as the imaging modality of choice for malignant PC/PGL.
Ga-DOTATATE (or
Ga-DOTATOC/
Ga-DOTANOC) PET-CT has high sensitivity for SDHx-mutated PC/PGL and serves for planning of radioreceptor therapy with somatostatin analogues. In contrast,
I-metaiodobenzylguanidine (MIBG) scintigraphy is important in assessing the potential efficacy of radioreceptor therapy with MIBG.
The CT protocol for PC evaluation should include non-enhanced, arterial, portal-venous and late phases; the latter for the evaluation of wash-out. Recent studies indicate non-enhanced CT alone may be sufficient to rule out PC. For MRI, in- and opposed-phase sequences should be additionally acquired.
A relevant proportion of PC is diagnosed incidentally. Therefore, imaging of PC will gain further importance. Recent studies show better response rates of PC/PGL after radioreceptor therapy with somatostatin analogues (
Lu-DOTATATE) than with MIBG. Therefore,
Ga-DOTATATE PET-CT gains further importance-for diagnostic imaging and therapy planning. |
doi_str_mv | 10.1007/s00117-019-0569-7 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2263321678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2263321678</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-2bde1b8300c609b4faa4654ffbde41e9a6120b14badc6d9be57ba733fbb91f5a3</originalsourceid><addsrcrecordid>eNo1j0FLwzAYhoMgbk5_gBfp0Us0X5KmjTcZUwcDPei5fEmTrtI2NekO-_dWnKcXHh5e3peQG2D3wFjxkBgDKCgDTVmuNC3OyBKk4JQD4wtymdLXbHDN9QVZCBCizHm5JJv3vQt2H0Mf7HEKPWY41NmIERscmq79JY_Zth9DnHCwLgs-q1tshpCm1mZtj007NFfk3GOX3PUpV-TzefOxfqW7t5ft-mlHR5AwUW5qB6YUjFnFtJEeUapcej9zCU6jAs4MSIO1VbU2Li8MFkJ4YzT4HMWK3P31jjF8H1yaqr5N1nUdDi4cUsW5EoKDKspZvT2pB9O7uhrjvDUeq__r4gfsXlpn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2263321678</pqid></control><display><type>article</type><title>Pheochromocytoma and paraganglioma : Importance of diagnostic imaging</title><source>Alma/SFX Local Collection</source><creator>Kunz, W G ; Auernhammer, C J ; Nölting, S ; Pfluger, T ; Ricke, J ; Cyran, C C</creator><creatorcontrib>Kunz, W G ; Auernhammer, C J ; Nölting, S ; Pfluger, T ; Ricke, J ; Cyran, C C</creatorcontrib><description>If pheochromocytoma (PC) or paraganglioma (PGL) is diagnosed based on serologic studies, imaging is required to locate the adrenal mass for further management. Besides pathognomonic hormonal findings, PC/PGL can exhibit typical imaging features. However, PC/PGL can also show morphological overlap with other pathologies.
The modality of choice for evaluation of PC is CT. In case of extra-adrenal location, MRI is superior to CT. Imaging with PET-CT provides complementary information in the differentiation of PC/PGL and is recommended as the imaging modality of choice for malignant PC/PGL.
Ga-DOTATATE (or
Ga-DOTATOC/
Ga-DOTANOC) PET-CT has high sensitivity for SDHx-mutated PC/PGL and serves for planning of radioreceptor therapy with somatostatin analogues. In contrast,
I-metaiodobenzylguanidine (MIBG) scintigraphy is important in assessing the potential efficacy of radioreceptor therapy with MIBG.
The CT protocol for PC evaluation should include non-enhanced, arterial, portal-venous and late phases; the latter for the evaluation of wash-out. Recent studies indicate non-enhanced CT alone may be sufficient to rule out PC. For MRI, in- and opposed-phase sequences should be additionally acquired.
A relevant proportion of PC is diagnosed incidentally. Therefore, imaging of PC will gain further importance. Recent studies show better response rates of PC/PGL after radioreceptor therapy with somatostatin analogues (
Lu-DOTATATE) than with MIBG. Therefore,
Ga-DOTATATE PET-CT gains further importance-for diagnostic imaging and therapy planning.</description><identifier>EISSN: 1432-2102</identifier><identifier>DOI: 10.1007/s00117-019-0569-7</identifier><identifier>PMID: 31338528</identifier><language>ger</language><publisher>Germany</publisher><subject>Adrenal Gland Neoplasms - diagnostic imaging ; Diagnosis, Differential ; Humans ; Paraganglioma - diagnostic imaging ; Pheochromocytoma - diagnostic imaging ; Positron Emission Tomography Computed Tomography - methods ; Positron-Emission Tomography - methods</subject><ispartof>Radiologe, 2019-11, Vol.59 (11), p.975-981</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31338528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kunz, W G</creatorcontrib><creatorcontrib>Auernhammer, C J</creatorcontrib><creatorcontrib>Nölting, S</creatorcontrib><creatorcontrib>Pfluger, T</creatorcontrib><creatorcontrib>Ricke, J</creatorcontrib><creatorcontrib>Cyran, C C</creatorcontrib><title>Pheochromocytoma and paraganglioma : Importance of diagnostic imaging</title><title>Radiologe</title><addtitle>Radiologe</addtitle><description>If pheochromocytoma (PC) or paraganglioma (PGL) is diagnosed based on serologic studies, imaging is required to locate the adrenal mass for further management. Besides pathognomonic hormonal findings, PC/PGL can exhibit typical imaging features. However, PC/PGL can also show morphological overlap with other pathologies.
The modality of choice for evaluation of PC is CT. In case of extra-adrenal location, MRI is superior to CT. Imaging with PET-CT provides complementary information in the differentiation of PC/PGL and is recommended as the imaging modality of choice for malignant PC/PGL.
Ga-DOTATATE (or
Ga-DOTATOC/
Ga-DOTANOC) PET-CT has high sensitivity for SDHx-mutated PC/PGL and serves for planning of radioreceptor therapy with somatostatin analogues. In contrast,
I-metaiodobenzylguanidine (MIBG) scintigraphy is important in assessing the potential efficacy of radioreceptor therapy with MIBG.
The CT protocol for PC evaluation should include non-enhanced, arterial, portal-venous and late phases; the latter for the evaluation of wash-out. Recent studies indicate non-enhanced CT alone may be sufficient to rule out PC. For MRI, in- and opposed-phase sequences should be additionally acquired.
A relevant proportion of PC is diagnosed incidentally. Therefore, imaging of PC will gain further importance. Recent studies show better response rates of PC/PGL after radioreceptor therapy with somatostatin analogues (
Lu-DOTATATE) than with MIBG. Therefore,
Ga-DOTATATE PET-CT gains further importance-for diagnostic imaging and therapy planning.</description><subject>Adrenal Gland Neoplasms - diagnostic imaging</subject><subject>Diagnosis, Differential</subject><subject>Humans</subject><subject>Paraganglioma - diagnostic imaging</subject><subject>Pheochromocytoma - diagnostic imaging</subject><subject>Positron Emission Tomography Computed Tomography - methods</subject><subject>Positron-Emission Tomography - methods</subject><issn>1432-2102</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo1j0FLwzAYhoMgbk5_gBfp0Us0X5KmjTcZUwcDPei5fEmTrtI2NekO-_dWnKcXHh5e3peQG2D3wFjxkBgDKCgDTVmuNC3OyBKk4JQD4wtymdLXbHDN9QVZCBCizHm5JJv3vQt2H0Mf7HEKPWY41NmIERscmq79JY_Zth9DnHCwLgs-q1tshpCm1mZtj007NFfk3GOX3PUpV-TzefOxfqW7t5ft-mlHR5AwUW5qB6YUjFnFtJEeUapcej9zCU6jAs4MSIO1VbU2Li8MFkJ4YzT4HMWK3P31jjF8H1yaqr5N1nUdDi4cUsW5EoKDKspZvT2pB9O7uhrjvDUeq__r4gfsXlpn</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Kunz, W G</creator><creator>Auernhammer, C J</creator><creator>Nölting, S</creator><creator>Pfluger, T</creator><creator>Ricke, J</creator><creator>Cyran, C C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201911</creationdate><title>Pheochromocytoma and paraganglioma : Importance of diagnostic imaging</title><author>Kunz, W G ; Auernhammer, C J ; Nölting, S ; Pfluger, T ; Ricke, J ; Cyran, C C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-2bde1b8300c609b4faa4654ffbde41e9a6120b14badc6d9be57ba733fbb91f5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2019</creationdate><topic>Adrenal Gland Neoplasms - diagnostic imaging</topic><topic>Diagnosis, Differential</topic><topic>Humans</topic><topic>Paraganglioma - diagnostic imaging</topic><topic>Pheochromocytoma - diagnostic imaging</topic><topic>Positron Emission Tomography Computed Tomography - methods</topic><topic>Positron-Emission Tomography - methods</topic><toplevel>online_resources</toplevel><creatorcontrib>Kunz, W G</creatorcontrib><creatorcontrib>Auernhammer, C J</creatorcontrib><creatorcontrib>Nölting, S</creatorcontrib><creatorcontrib>Pfluger, T</creatorcontrib><creatorcontrib>Ricke, J</creatorcontrib><creatorcontrib>Cyran, C C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Radiologe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kunz, W G</au><au>Auernhammer, C J</au><au>Nölting, S</au><au>Pfluger, T</au><au>Ricke, J</au><au>Cyran, C C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pheochromocytoma and paraganglioma : Importance of diagnostic imaging</atitle><jtitle>Radiologe</jtitle><addtitle>Radiologe</addtitle><date>2019-11</date><risdate>2019</risdate><volume>59</volume><issue>11</issue><spage>975</spage><epage>981</epage><pages>975-981</pages><eissn>1432-2102</eissn><abstract>If pheochromocytoma (PC) or paraganglioma (PGL) is diagnosed based on serologic studies, imaging is required to locate the adrenal mass for further management. Besides pathognomonic hormonal findings, PC/PGL can exhibit typical imaging features. However, PC/PGL can also show morphological overlap with other pathologies.
The modality of choice for evaluation of PC is CT. In case of extra-adrenal location, MRI is superior to CT. Imaging with PET-CT provides complementary information in the differentiation of PC/PGL and is recommended as the imaging modality of choice for malignant PC/PGL.
Ga-DOTATATE (or
Ga-DOTATOC/
Ga-DOTANOC) PET-CT has high sensitivity for SDHx-mutated PC/PGL and serves for planning of radioreceptor therapy with somatostatin analogues. In contrast,
I-metaiodobenzylguanidine (MIBG) scintigraphy is important in assessing the potential efficacy of radioreceptor therapy with MIBG.
The CT protocol for PC evaluation should include non-enhanced, arterial, portal-venous and late phases; the latter for the evaluation of wash-out. Recent studies indicate non-enhanced CT alone may be sufficient to rule out PC. For MRI, in- and opposed-phase sequences should be additionally acquired.
A relevant proportion of PC is diagnosed incidentally. Therefore, imaging of PC will gain further importance. Recent studies show better response rates of PC/PGL after radioreceptor therapy with somatostatin analogues (
Lu-DOTATATE) than with MIBG. Therefore,
Ga-DOTATATE PET-CT gains further importance-for diagnostic imaging and therapy planning.</abstract><cop>Germany</cop><pmid>31338528</pmid><doi>10.1007/s00117-019-0569-7</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1432-2102 |
ispartof | Radiologe, 2019-11, Vol.59 (11), p.975-981 |
issn | 1432-2102 |
language | ger |
recordid | cdi_proquest_miscellaneous_2263321678 |
source | Alma/SFX Local Collection |
subjects | Adrenal Gland Neoplasms - diagnostic imaging Diagnosis, Differential Humans Paraganglioma - diagnostic imaging Pheochromocytoma - diagnostic imaging Positron Emission Tomography Computed Tomography - methods Positron-Emission Tomography - methods |
title | Pheochromocytoma and paraganglioma : Importance of diagnostic imaging |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A31%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pheochromocytoma%20and%20paraganglioma%20:%20Importance%20of%20diagnostic%20imaging&rft.jtitle=Radiologe&rft.au=Kunz,%20W%20G&rft.date=2019-11&rft.volume=59&rft.issue=11&rft.spage=975&rft.epage=981&rft.pages=975-981&rft.eissn=1432-2102&rft_id=info:doi/10.1007/s00117-019-0569-7&rft_dat=%3Cproquest_pubme%3E2263321678%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p141t-2bde1b8300c609b4faa4654ffbde41e9a6120b14badc6d9be57ba733fbb91f5a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2263321678&rft_id=info:pmid/31338528&rfr_iscdi=true |